• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Inc

+ Add to Watchlist

THRX:US

14.3200 USD 1.3600 10.49%

As of 17:20:00 ET on 12/17/2014.

Snapshot for Theravance Inc (THRX)

Open: 12.9700 Day's Range: 12.9100 - 14.6400 Volume: 1,793,081
Previous Close: 12.9600 52wk Range: 12.5600 - 32.8819 1-Yr Rtn: -49.28%

Stock Chart for THRX

No chart data available.
  • THRX:US 14.3000
  • 1D
  • 1M
  • 1Y
12.9600
Interactive THRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for THRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.4500
Est. EPS (USD) (12/2014) -1.0780
Est. PEG Ratio -
Market Cap (M USD) 1,652.08
Shares Outstanding (M) 115.37
30 Day Average Volume 951,245
Price/Book (mrq) -
Price/Sale (ttm) 422.2096
Dividend Indicated Gross Yield 6.98%
Cash Dividend (USD) 0.2500
Dividend Ex-Date 11/21/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for THRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for THRX

Theravance Inc., is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders.

Michael W AguiarPresident/CEOEric D'EsparbesSenior VP/CFO
George B AbercrombieSenior VP:Corporate PartnershipsTheodore J WitekSenior VP:Corporate Partnerships
More Company Profile & Key Executives for THRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil